ReviewJournal of inflammation research2025
Crosstalk Between Keratinocytes and T Cells in Ulcerative Oral Mucosal Diseases: Mechanisms of Epithelial Dysfunction and Therapeutic Perspectives.
Review in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- GPR55 negatively regulates CD8Journal of molecular histology · 2026Article
- Self-oxidatively crosslinked sprayable hydrogel for microenvironment remodeling and accelerated healing of recurrent aphthous ulcers.Materials today. Bio · 2026Article
- Remodeling mechanisms and intervention strategies of the oral mucosal immune barrier.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Erosive and ulcerative oral mucosal diseases (OMDs) are characterized by persistent inflammation, epithelial barrier disruption, and impaired tissue repair, including oral lichen planus (OLP), discoid lupus erythematosus (DLE), pemphigus vulgaris (PV), mucous membrane pemphigoid (MMP), and recurrent aphthous ulcers (RAU). Aberrant activation of T cells induces cytotoxic and cytokine-mediated injury to the oral mucosa, impairing epithelial stem cell (EpSC) function, damaging the basement membrane, and compromising epithelial regeneration, which eventually results in sustained barrier failure. Under physiological conditions, EpSCs maintain mucosal resilience through continuous self-renewal and rapid turnover. In ulcerative OMDs, however, T cells drive inflammatory signals disrupt these processes. To systematically understand these mechanisms, this review summarizes current evidence on disease specific T cell subsets, cytokine networks, and keratinocyte responses that drive oral epithelial dysfunction. It also highlights emerging therapeutic strategies aimed at restoring epithelial homeostasis by targeting T cell and keratinocyte interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.